Tag: respiratory disease
Australia invests in local manufacturing of AI tools for respiratory disease
Australian health technology company Diag-Nose.io has secured $3 million in federal funding to advance local manufacturing and clinical validation of an artificial intelligence-powered diagnostic platform designed to improve treatment of respiratory disease.
Featured Article
Modular switchgear built for faster, verified panel builds
As switchboard builders face tighter programmes and increasing scrutiny around compliance, the way enclosure, busbar and separation concepts work together has a direct impact on build time and verification effort.
